Synthesis and optimization of cholesterol-based diquaternary ammonium gemini surfactant (Chol-GS) as a new gene delivery vector

Journal of Microbiology and Biotechnology

Volumn 21, Issue 1, 2011, Pages 93-99

  Kim, Bieong Kil ^a   Doh, Kyung Oh ^b   Bae, Yun Ui ^b   Seu, Young Bae ^a  

^a Kyungpook National University   (South Korea)

^b Yeungnam University College of Medicine   (South Korea)

Author keywords

Cationic liposome; Cholesterol; Gemini surfactant; Gene therapy; Transfection

Indexed keywords

1,2 DIMYRISTYLOXYPROPYL 3 DIMETHYLHYDROXYETHYLAMMONIUM BROMIDE; 1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; 1,2 DIOLEOYL ALPHA GLYCERO 3 PHOSPHATIDYLETHANOLAMINE; CHOLESTEROL; LIPOFECTAMINE; LIPOSOME; QUATERNARY AMMONIUM DERIVATIVE; SURFACTANT; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; CELL STRAIN COS7; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; GENE TRANSFER; IN VITRO STUDY; MOLECULAR WEIGHT; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PARTICLE SIZE;

ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; CHOLESTEROL; COS CELLS; GENE TRANSFER TECHNIQUES; HUMANS; LIPOSOMES; QUATERNARY AMMONIUM COMPOUNDS; SURFACE-ACTIVE AGENTS;

EID: 79251623411     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: 10.4014/jmb.1008.08012     Document Type: Article

References (23)

1. Bajaj, A., P. Kondiah, and S. Bhattacharya. 2007. Design, synthesis, and in vitro gene delivery efficacies of novel cholesterol-based gemini cationic lipids and their serum compatibility: A structure-activity investigation. J. Med. Chem. 50: 2432-2442.
2. Bajaj, A., B. Paul, S. S. Indi, P. Kondaiah, and S. Bhattacharya. 2007. Effect of the hydrocarbon chain and polymethylene spacer lengths on gene transfection efficacies of gemini lipids based on aromatic backbone. Bioconjug. Chem. 18: 2144-2158.
3. Chien, P. Y., J. Wang, D. Carbonaro, S. Lei, B. Miller, S. Sheikh, S. M. Ali, M. U. Ahmad, and I. Ahmad. 2005. Novel cationic cardiolipin analogue-based liposome for efficient DNA and small interfering RNA delivery in vitro and in vivo. Cancer Gene Ther. 12: 321-328.
4. Farhood, H., N. Serbina, and L. Huang. 1995. The role of dioleoyl phosphatidylethanol-amine in cationic liposome mediated gene transfer. Biochim. Biophys. Acta 1235: 289-295.
5. Felgner, J. H., R. Kumar, C. N. Sridhar, C. J. Wheeler, Y. J. Tsai, R. Border, P. Ramsey, M. Martin, and P. L. Felgner. 1994. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J. Biol. Chem. 269: 2550-2561.
6. Felgner, P. L., T. R. Gadek, M. Holm, R. Roman, H. W. Chan, M. Wenz, J. P. Northrop, G. M. Ringold, and M. Danielsen. 1987. Lipofection: A highly efficient, lipid-mediated DNAtransfection procedure. Proc. Natl. Acad. Sci. USA 84: 7413-7417.
7. Friedmann, T. 1996. Human gene therapy - an immature genie, but certainly out of the bottle. Nat. Med. 2: 144-147.
8. Hafez, I. M., N. Maurer, and P. R. Cullis. 2001. On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids. Gene Ther. 8: 1188-1196.
9. Hollon, T. 2000. Researchers and regulators reflect on first gene therapy death. Nat. Med. 6: 6.
10. Hope, M. J., B. Mui, S. Ansell, and Q. F. Ahkong. 1998. Cationic lipids, phosphatidyl-ethanolamine and the intracellular delivery of polymeric, nucleic acid-based drugs (Review). Mol. Membr. Biol. 15: 1-14.
11. Ilies, M. A., W. A. Seitz, B. H. Johnson, E. L. Ezell, A. L. Miller, E. B. Thompson, and A. T. Balaban. 2006. Lipophilic pyrylium salts in the synthesis of efficient pyridinium-based cationic lipids, gemini surfactants, and lipophilic oligomers for gene delivery. J. Med. Chem. 49: 3872-3887.
12. Karmali, P. P. and A. Chaudhuri. 2007. Cationic liposomes as non-viral carriers of gene medicines: Resolved issues, open questions and future promises. Med. Res. Rev. 27: 696-722.
13. Kasireddy, K., S. M. Ali, M. U. Ahmad, S. Choudhury, P. Y. Chien, S. Sheikh, and I. Ahmad. 2005. Synthesis of cationic cardiolipin analogues. Bioorg. Chem. 33: 345-362.
14. Kay, M. A., J. C. Glorioso, and L. Naldini. 2001. Viral vectors for gene therapy: The art of turning infectious agents into vehicles of therapeutics. Nat. Med. 7: 33-40.
15. Li, Z., J. Düllmann, B. Schiedlmeier, M. Schmidt, C. von Kalle, J. Meyer, et al. 2002. Murine leukemia induced by retroviral gene marking. Science 296: 497.
16. Marshall, E. 2002. Gene therapy: What to do when clear success comes with an unclear risk. Science 298: 510-511.
17. Miller, A. D. 2003. The Problem with cationic liposome/ micelle-based non-viral vector systems for gene therapy. Curr. Med. Chem. 10: 1195-1211.
18. Rosenzweig, H. S., V. A. Rakhmanova, and R. C. MacDonald. 2001. Diquaternary ammonium compounds as transfection agents. Bioconjug. Chem. 12: 258-263.
19. Van der Woude, I., A. Wagenaar, A. A. Meekel, M. B. ter Beest, M. H. Ruiters, J. B. Engberts, and D. Hoekstra. 1997. Novel pyridinium surfactants for efficient, nontoxic in vitro gene delivery. Proc. Natl. Acad. Sci. USA 94: 1160-1165.
20. Wang, J., X. Guo, Y. Xu, L. Barron, and F. C. Jr. Szoka. 1998. Synthesis and characterization of long chain alkyl acyl carnitine esters. Potentially biodegradable cationic lipids for use in gene delivery. J. Med. Chem. 41: 2207-2215.
21. Woods, N. B., A. Muessig, M. Schmidt, J. Flygare, K. Olsson, P. Salmon, D. Trono, C. von Kalle, and S. N. B. Karlsson. 2003. Lentiviral vector transduction of NOD/SCID repopulating cells results in multiple vector integrations per transduced cell: Risk of insertional mutagenesis. Blood 101: 1284-1289.
22. Yoshimura, T., S. Hasegawa, N. Hirashima, M. Nakanishi, and T. Ohwada. 2001. Anchoring and bola cationic amphiphiles for nucleotide delivery. Effects of orientation and extension of hydrophobic regions. Bioorg. Med. Chem. Lett. 11: 2897-2901.
23. Zabner, J., A. J. Fasbender, T. Moninger, K. A. Poellinger, and M. J. Welsh. 1995. Cellular and molecular barriers to gene transfer by a cationic lipid. J. Biol. Chem. 270: 18997-19007.